USAID Progress: The U.S. National Vaccine Plan of 1994
|
|
- Harvey Craig
- 6 years ago
- Views:
Transcription
1 USAID Progress: The U.S. National Vaccine Plan of 1994 Ellyn Ogden Neal Brandes Angela Weaver Washington DC March 3, 2008
2 Objective 1.1/1.5 (New Vaccines) Support to GAVI for introduction of new vaccines in developing countries (e.g., rotavirus, PCV, Hib) Support to the Meningitis Vaccine Project (MVP) and its novel approach to the development of a conjugate meningitis group A vaccine for use in developing countries 30 years of investment to support a safe and effective malaria vaccine for children
3 Objective: 4.5 (Surveillance for VPDs) VPD surveillance Field Epidemiology training Integrated Disease Surveillance and Response Polio Lab Net 147 labs Many labs expanded to include measles, tetanus, rubella, yellow fever Polio Surveillance Facility-based: 24 countries; ~ 500 medical officers; polio, MNT, measles Community-based: 4 countries; ~ 30,000 case detection volunteers; polio, MNT, measles
4 Objective 4.6 (Tracking Systems) Newborn and Immunization tracking systems implemented in CORE NGO project areas: India, Nepal, Ethiopia, Angola Immunization Registries: Egypt, Indonesia Post-Campaign Monitoring: Polio
5 Objective 4.8 (International Travelers) Wide dissemination of Immunization requirements for Hadjj Cross Border Immunization e.g. Nigeria/Niger, Afghanistan/Pakistan
6 Objective 4.9 (Polio Eradication) 99% reduction in cases (from 1000 cases per day to 1300 per year) 4 endemic countries (India, Pakistan, Afghanistan, Nigeria) 10 of 13 post-nigerian cessation reinfected countries again polio-free 6 million cases of paralysis averted mopv1 and mopv3 USAID annual investment: $32 million, including: Surveillance and LabNet Human resources, training, cell lines and reagents, data quality and use Supplemental Immunization Delivering vaccine (e.g., planning, monitoring, cross border coordination) Communication / Social Mobilization (e.g., human resources (50,000 mobilizers), civil society, data collection and analysis, increasing awareness), social mapping epidemiology/social/cultural/campaign data Diplomacy and Advocacy (e.g. G8, World Health Assembly)
7 Progress Since Today * as of 20 Feb endemic countries 1000 cases per DAY! 2007* 4 endemic countries (India, Nigeria, Pakistan, Afghanistan) 6 countries with active outbreaks b/t Aug 07 Feb 08 (Nepal, Angola, Niger, Chad, D.R.Congo, Sudan) 1300 cases per YEAR!
8 Objective 4.10 (maternal and neonatal tetanus (MNT) & measles control) Country specific support for measles campaigns: e.g. AFG, Nigeria, DR Congo Country specific support for MNT control: integrated MCH, school-based initiatives e.g. Indonesia Surveillance
9 Objective: 4.11 (Sustainability) GAVI: USAID $69 million annually Co-financing Health Systems Strengthening: to address the system barriers to improving immunization and other MCH outcomes Accelerated Development and Implementation Plans (ADIPS) Injection Safety IFFm: International Finance Facility for Immunization (not USAID funded) AMC Advance Market commitments (not USAID funded) Routine Immunization: Bilateral Project and Central Level Technical Assistance: Management, Data Quality, financing, policy development, communication and community mobilization National Regulatory Authorities advocacy and technical assistance
10 The Way Forward New global public health initiatives and new actors bring new opportunities and challenges Need to work within host-country policies and plans and be sensitive to community concerns Increased participation by domestic USG agencies is an opportunity for coordination into unified foreign aid policy role in international partnerships Research-to-use strategies support for research and innovation flexibility and collaboration of USG agencies Rotavirus, PCV, Hib Malaria Avian Influenza HIV/AIDS Polio Measles
11 Improving Health Outcomes: Role of USAID in the New Global Landscape for Research on Special Problems of Developing Countries Health Assessment/ Priority Setting Basic Research Applied Research/ Development/ Adaptation Field Implementation and Evaluation Task Disease surveillance Assessments of burden of disease Identification of critical knowledge gaps Product development Field trials Consumer research Modification of existing products Adaptation at scale Strengthening national health systems Monitor program effectiveness and modify approaches Performance Local agencies USAID (major)/cdc Bilateral donors NIH Pharmaceutical companies International foundations Local research organizations Pharmaceutical and medical supply companies Local research Organizations USAID Bilateral donors Local agencies USAID (major) Global Fund WHO Bilateral donors PEPFAR Improved Health Outcomes Source: National Research Council The Fundamental Role of Science and Technology in International Development: An Imperative for the U.S. Agency for International Development. Washington: National Academies Press.
12 Accountability Performance monitoring focused on scaling up country and global tracking indicators (e.g., DHS, JRFs, MICs, etc.) Annual reporting on progress Office of Foreign Assistance and Congress
Task Force on Immunization (TFI) in Africa 14 th Annual Meeting. And. Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting
Task Force on Immunization (TFI) in Africa 14 th Annual Meeting And Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting Meeting Report Maputo, Mozambique 27 29 November 2006
More informationGavi s strategic framework 22 June 2016
Gavi s 2016 2020 strategic framework 22 June 2016 Gavi 2000-2015 Gavi 3.0 Gavi 2.0 250 million children immunised Gavi 1.0 90m children immunised 200 million children immunised 2000 2005 2006 2010 2011
More informationSudan EPI Benefits From Polio Eradication Program
Federal Ministry of Health Primary Health Care Maternal and Child Health Expanded Program on Immunization Sudan EPI Benefits From Polio Eradication Program Polio Legacy Planning and Implementation Workshop
More informationGlobal Immunization Overview. Thomas Cherian Expanded Programme on Immunization WHO, Geneva
Global Immunization Overview Thomas Cherian Expanded Programme on Immunization WHO, Geneva Global U5 Mortality: Role of Vaccine Preventable Diseases (2008 data) 8.8 million under five deaths Other 20%
More informationWHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES
WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES Immunization and vaccine development in the last decade Since the Millennium Summit in 2000, immunization substantial international
More informationPolio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions
Polio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions Global Polio Partners Group (PPG) meeting June 26, 2017 Underlying premise: Transition
More informationVACCINE MARKETS OVERVIEW SESSION
VACCINE MARKETS OVERVIEW SESSION Robyn Iqbal Program Officer, Vaccine Delivery Market Dynamics UNICEF SD Manufacturers Meeting Copenhagen October 8, 2014 DRAFT Bill & Melinda Gates Foundation DISCUSSION
More informationUpdate from the GAVI Alliance Seth Berkley, MD Chief Executive Officer
Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer SAGE meeting Geneva, 8-10 November 2011 Topics to cover Update on new vaccine introduction Introductions New approvals Co-financing
More informationGlobal Health Policy: Vaccines
Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY
More informationPOLIO ERADICATION IN THE AFRICAN REGION: PROGRESS REPORT. Information document EXECUTIVE SUMMARY
7 July 2006 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-sixth session Addis Ababa, Ethiopia, 28 August 1 September 2006 Provisional agenda item 10.1 POLIO ERADICATION IN THE AFRICAN REGION: PROGRESS
More informationGlobal Immunizations & UNICEF s Role Dr. Robin Nandy Principal Advisor & Chief of Immunizations UNICEF Headquarters
Global Immunizations & UNICEF s Role Dr. Robin Nandy Principal Advisor & Chief of Immunizations UNICEF Headquarters UNICEF Vaccine Industry Consultation Copenhagen 5 October 2017 Outline Status & directions
More informationOverall presentation of IVR Strategy
Annex 3 Overall presentation of IVR Strategy Presentation to the IVR Advisory committee (IVAC) April 2007 Outline Why does WHO invest in Research & Development? What is the Initiative for Vaccine Research
More informationPrioritizing Emergency Polio Eradication Activities
Prioritizing Emergency Polio Eradication Activities Managing the Financing Gap the other half of the Emergency Hamid Jafari GPEI Financing 2012-13: Budget = $2.23 b - Confirmed contributions = $1.14 b
More informationFISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated ) USAID Global Health Programs (GHP) and State Department
FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated 2.13.19) Contact: Brian Massa, Senior Manager for Global Health Advocacy, Shot@Life (bmassa@unfoundation.org) USAID Global Health Programs (GHP) and State
More informationLaunch of a supplement in Health Policy and Planning. Dr. Joy Lawn Mary Kinney Anne Pfitzer On behalf of the team
A Decade of Change for Newborn Survival Launch of a supplement in Health Policy and Planning Dr. Joy Lawn Mary Kinney Anne Pfitzer On behalf of the team Overview of the supplement Editorial Gary Darmstadt,
More informationMaternal and Neonatal Tetanus Elimination by Yes, We Can! Global Immunization Meeting 18 th February 2009
Maternal and Neonatal Tetanus Elimination by 2012 Yes, We Can! Global Immunization Meeting 18 th February 2009 OUTLINE Can we eliminate MNT by 2012? Can MNTE contribute to MDG4? Can TT-SIAs help to deliver
More informationGAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS
GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS Ranjana Kumar International Rotavirus Symposium Istanbul, 3 4 June 2008 The GAVI Alliance Public-private partnership bringing
More informationUpdate from GAVI Aurelia Nguyen
Update from GAVI Aurelia Nguyen (Copenhagen, Denmark, 27 June 2012) GAVI vaccine support Currently supported vaccines: pentavalent, pneumococcal, rotavirus, meningitis A, human papillomavirus (HPV), rubella,
More informationReport to the Board 6-7 June 2018
Report to the Board 6-7 June 2018 SUBJECT: Category: PROGRAMME AND POLICY COMMITTEE CHAIR REPORT For Information Section A: Introduction This report provides the Board with an overview of the activities
More informationCenter for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home
Center for Global Health CDC Global Health Saving Lives Overseas, Protecting Americans at Home CDC Overview Part of the U.S. Department of Health and Human Services, CDC is the nation s leading public
More informationMidterm Review of the Global Measles and Rubella Strategic Plan W. A. Orenstein, MD SAGE Geneva, 19 October 2016
Midterm Review of the Global Measles and Rubella Strategic Plan 2012 2020 W. A. Orenstein, MD SAGE Geneva, 19 October 2016 1 Outline Strategic Plan 2012-2020 Progress toward milestones and goals Objectives
More informationProgress Towards Global Polio Eradication by 2012: Progress and Ongoing Challenges
Progress Towards Global Polio Eradication by 2012: Progress and Ongoing Challenges European Conference on Post Polio Syndrome 31 August 2 September 2011, Copenhagen, Denmark Dr Rebecca Martin Vaccine Preventable
More informationWild Poliovirus*, 03 Aug 2004 to 02 Aug 2005
Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild virus type 1 Wild virus type 3 Wild virus type 1 & 3 Endemic countries Re-established transmission countries Case or outbreak following importation *Excludes
More informationCEO Board report Seth Berkley MD CEO
CEO Board report Seth Berkley MD CEO Dhaka, Bangladesh, 16 17 November 2011 Bangladesh, November 2011 Meningitis Incidence Children < 12 months Dhaka Shishu / Shishu Shahsta Catchment Area 2008 2011 1800
More informationGlobal reductions in measles mortality and the risk of measles resurgence
Global reductions in measles mortality 2000 2008 and the risk of measles resurgence Measles is one of the most contagious human diseases. In 1980 before the use of measles vaccine was widespread, there
More informationTFI Proceedings, Recommendations and implications for 2005
January 2005 N 053 TFI 2004 - Proceedings, Recommendations and implications for 2005 The 12th meeting of the Task Force on Immunization (TFI) in Africa and the 11th meeting of the Africa Regional Inter-
More information1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector
1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast (2006 ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 ) 4. Worldwide Pediatric Vaccines Market Share
More informationGAVI S VACCINE INVESTMENT STRATEGY
GAVI S VACCINE INVESTMENT STRATEGY Judith Kallenberg, Head of Policy PDVAC 22 June 2017, Geneva Reach every child www.gavi.org Gavi finances vaccines and immunisation through three routes ($9 Billion in
More informationPolio post-certification strategy
1 Polio post-certification strategy SAGE Meeting, Geneva, 17 April 2018 Michel Zaffran, Director, Polio Eradication, WHO On Behalf o the GPEI Polio Eradication and Endgame Strategy 1. Poliovirus detection
More informationFrom development to delivery: Decision-making for the introduction of a new vaccine
From development to delivery: Decision-making for the introduction of a new vaccine Prince Mahidol Award Conference Bangkok, Thailand 1-2 February 2007 Dr. J.M. Okwo-Bele Department of Immunization, Vaccines
More informationGlobal Report to SAGE. Fulfillment of previous recommendations & progress highlights
Global Report to SAGE Fulfillment of previous recommendations & progress highlights SAGE Meeting, 8-10 November 2012 J.M. Okwo-Bele, WHO Outline 1 2 3 4 Global progress Regional updates- RTAGs recommendations
More informationThe Financial Sustainability of New Vaccine Introduction in the Poorest Countries :
The Financial Sustainability of New Vaccine Introduction in the Poorest Countries : Evidence from the First Phase of GAVI (Global Alliance for Vaccines and Immunization) Patrick Lydon lydonp@who.int Session:
More informationImmunization Update & focus on meningococcal vaccine PART 1
Immunization Update & focus on meningococcal vaccine PART 1 Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases University of Cape Town www.vacfa.uct.ac.za Disclosures Received
More informationFY2017 Q1: CORE Group Polio Project (CGPP) Quarterly Update
FY17 Q1: CORE Group Polio Project (CGPP) Quarterly Update CGPP Partnerships During the first quarter of the 17 fiscal year, the CORE Group Polio Project implemented activities in six countries: Ethiopia,
More informationGlobal Overview Polio Partners Group, December Note: Gavi requirements of $122.2 million are not included in this slide
Global Overview Polio Partners Group, December 2015 1 Note: Gavi requirements of $122.2 million are not included in this slide The Polio Endgame Plan 1. Poliovirus detection & interruption 2. OPV2 withdrawal,
More informationReport to the. GAVI Alliance Board June 2013
Report to the GAVI Alliance Board 11-12 June 2013 Subject: Report of: Authored by: Risk Management Update Helen Evans, Deputy CEO Ciara Goldstein, Analyst, Performance Management and Adrien de Chaisemartin,
More informationStrengthening and integrating MNCH. Partners forum Meeting April,17-21/2007 Dar es Salaam,Tanzaniay
Ethiopia Strengthening and integrating MNCH Partners forum Meeting April,17-21/2007 Dar es Salaam,Tanzaniay Outline 1. Back ground Key demographic data How many die? National progress to MDG 4 and 5 Causes
More informationHPV Vaccine Lessons Learned & New Ways Forward
HPV Vaccine Lessons Learned & New Ways Forward The Gavi Alliance June 2016, Geneva www.gavi.org Overview 1 Background 2 Lessons learned 3 New Way Forward 2 1 Background 3 HPV Background HPV is responsible
More informationPOLIO ERADICATION AND POST-CERTIFICATION STRATEGY
POLIO ERADICATION AND POST-CERTIFICATION STRATEGY PRE-BOARD MEETING 5 June 2018, Geneva Reach every child www.gavi.org Agenda Topic Presenter 1. Polio eradication update WHO 10 minutes 2. IPV supply, demand
More informationPNEUMONIA & DIARRHEA PROGRESS REPORT APPENDIX
2017 PNEUMONIA & DIARRHEA PROGRESS REPORT APPENDIX i To see online report and Appendix, please visit: www.jhsph.edu/research/centers-and-institutes/ivac/resources/ivac-2017-pneumonia-diarrhea-progress-report.pdf
More informationVaccine Preventable Disease Surveillance: Overview. Thomas Cherian, WHO
Vaccine Preventable Disease Surveillance: Overview Thomas Cherian, WHO Global Framework on Immunization Monitoring and Surveillance (GFIMS) l An extension of the GIVS, published on December 07 - http://www.who.int/immunization/en/
More informationDr. Collins Tabu KPA Conference, 26 th April 2018 Mombasa, Kenya
Dr. Collins Tabu KPA Conference, 26 th April 2018 Mombasa, Kenya Presentation Outline Background Immunization Performance review Available Opportunities for engagement Planned and ongoing strategies- New
More informationGlobal Health Policy: Vaccines
Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY
More informationAccess to vaccination in GAVI countries and at global level
Access to vaccination in GAVI countries and at global level Stefano Malvolti Director, Vaccine Implementation GAVI Alliance 15th ADVANCED COURSE OF VACCINOLOGY May 12, 2014 Global progress to MDG 4 for
More informationWild Poliovirus Weekly Update
1 of 5 12/07/2010 12:09 PM Google search this site contact links donate Home > Global Situation Wild Poliovirus Weekly Update 7 July 2010 Data as at 6 July 2010 Map of polio cases worldwide Wild poliovirus
More informationANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA
4 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 16 PROGRESS REPORT ON POLIOMYELITIS ERADICATION
More informationReport to the Board June 2015
10-11 June 2015 SUBJECT: Report of: Authored by: Agenda item: Category: MEASLES SUPPLEMENTARY IMMUNISATION ACTIVITIES Hind Khatib-Othman, Managing Director, Country Programmes Khin Devi Aung, Senior Programme
More informationEnding Malaria in Nigeria: The WHO Agenda
Nigeria Institute of Medical Research 2016 World Malaria Day Lecture 27 April, 2016 Ending Malaria in Nigeria: The WHO Agenda Dr Tolu Arowolo Malaria Containment Programme, WHO, Nigeria arowolot@who.int
More informationCONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN
23 September 2013 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-third session Brazzaville, Republic of Congo, 2 6 September, 2013 Agenda item 14 IMMUNIZATION IN THE AFRICAN REGION: PROGRESS REPORT
More informationEradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 September 2011
Eradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 Why? Polio Crippled for life Primarily affects children We have a historic opportunity. Preventable with vaccine 1955: polio
More informationA NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA
A NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA The Global Financing Facility in Support of Every Woman Every Child Photo by Maria Fleischmann WHY NOW? Photo by Dominic Chavez Countries have
More informationObjective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch
Objective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch Polio Partners Group meeting Geneva 8 December 2014 Michel Zaffran Coordinator, WHO/EPI, IMG Co-chair On behalf
More informationOverview. Vaccine innovation With people, for people: The (A) citizens' view. Vaccine impact in perspective. Vaccine research in perspective
Overview Vaccine innovation With people, for people: The (A) citizens' view Disclaimer about the citizen Ending AIDS? A history lesson A way forward hopefully Mitchell Warren Executive Director, AVAC 12
More informationBusiness Methods for Positive Global Health Impact
Business Methods for Positive Global Health Impact Gary M. Cohen Executive Vice President President, Global Health and Development BD IS ADDRESSING THE WORLD S LEADING HEALTH PROBLEMS THROUGH UNIQUE PUBLIC-PRIVATE
More informationHarnessing the power of vaccines using the public and private sector: A 21 st century model for international development
Harnessing the power of vaccines using the public and private sector: A 21 st century model for international development Dr. Seth Berkley, CEO GAVI Alliance Wellcome Trust Cambridge Centre for Global
More informationUpdate on Implementation of NUV. Carsten Mantel WHO/FCH/IVB/EPI
Update on Implementation of NUV Carsten Mantel WHO/FCH/IVB/EPI Introduction of New Vaccines The continuum of activity REGULATORY NORMS & STANDARDS VACCINE SUPPLY PROCUREMENT PRICING FINANCING SURVEILLANCE
More information3. CONCLUSIONS AND RECOMMENDATIONS
3. CONCLUSIONS AND RECOMMENDATIONS 3.1 Polio Endgame Strategy Conclusions 1. The TAG welcomes the RCC conclusion that Western Pacific Region maintains its polio-free status, and commends China for the
More informationAll About Vaccines and How They Get to Those Who Need Them Most. Elesha Kingshott
All About Vaccines and How They Get to Those Who Need Them Most Elesha Kingshott Shot@Life Four Priority Disease Areas 1. Polio 2. Measles 3. Diarrheal Disease 4. Pneumonia Polio is caused by a virus that
More informationNO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL. Measles & Rubella Campaigns
NO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL Measles & Rubella Campaigns With fewer than 600 days remaining to the Millennium Development Goal (MDG) deadline,
More informationVaccines. Global impact of a preventive technology. Edwin J. Asturias, MD
Vaccines Global impact of a preventive technology Edwin J. Asturias, MD Associate Professor of Pediatrics and Epidemiology Director for Latin America Center for Global Health, Colorado School of Public
More informationOkinawa, Toyako, and Beyond: Progress on Health and Development
Okinawa, Toyako, and Beyond: Progress on Health and Development Prof. Michel D. Kazatchkine Executive Director The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations University, Tokyo,
More informationThe power of partnership: the GAVI Alliance Board
The power of partnership: the GAVI Alliance Board 1 GAVI s mission To save children s lives and protect people s health by increasing access to immunisation in poor countries Strategic goals 2011 2015!
More informationGlobal Polio Eradication, Progress, Impact of Ebola, Risks & Opportunities. Polio Partners Group 8 December 2014
Global Polio Eradication, Progress, Impact of Ebola, Risks & Opportunities Polio Partners Group 8 December 2014 Outline Progress Impact of Ebola Priorities Risks Wild Poliovirus type 1 (WPV1) Cases, 2013
More information5 th Islamic Conference of Health Ministers. Resolution. Istanbul, Turkey November 2015 (5-7 Safar 1437H)
5 th Islamic Conference of Health Ministers Resolution Istanbul, Turkey 17-19 November 2015 (5-7 Safar 1437H) Draft Resolution No. 2/5-ICHM On Healthy Life Style, Prevention and Control of Communicable
More informationTargeted Diseases and Immunization. Strategic plan
Targeted Diseases and Immunization Strategic plan 2008-2013 Communicable Diseases Unit WHO Regional Office for Europe Mission To provide technical support to WHO European Region Member States to ensure
More informationPolio and measles control: opportunities and threats for health systems
Polio and measles control: opportunities and threats for health systems USAID Global Health Mini University March 4, 2016 Dr. Craig Burgess, JSI OVERVIEW Polio and measles: an overview Control strategies
More informationPromoting FP/RH-HIV/AIDS Integration: A Summary of Global Health Initiative Strategies in Ethiopia, Kenya, Tanzania, and Zambia
Promoting FP/RH-HIV/AIDS Integration: A Summary of Global Health Initiative Strategies in Ethiopia, Kenya, Tanzania, and Zambia The Global Health Initiative (GHI) is an integrated approach to global health
More informationThe Global Fund & UNICEF Partnership
The Global Fund & UNICEF Partnership Prof Michel D. Kazatchkine Executive Director UNICEF Executive Board February 9 th, 2011 The Global Fund Millennium Development Goals 1. Eradicate extreme poverty and
More information2016 NON FINANCIAL RESOURCE REQUIREMENTS GPEI DONOR CONTRIBUTIONS
2016 NON FINANCIAL RESOURCE REQUIREMENTS GPEI DONOR CONTRIBUTIONS Background The Global Polio Eradication Initiative (GPEI) is financed through a range of public and private donations. The Financial Resource
More informationGavi initiatives for improving vaccine supply
Gavi initiatives for improving vaccine supply Melissa Malhame DCVMN, 28 October 2014 A world free from vaccine preventable diseases www.gavi.org Agenda 1. Gavi Strategy 2011-2015, and supply and procurement
More informationExpanded Programme on Immunization (EPI)
Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationPerspectives on Ensuring Access to Vaccines in Lower Income Countries
Perspectives on Ensuring Access to Vaccines in Lower Income Countries Greg Widmyer Deputy Director, Vaccine Delivery Foundation Merieux January 20, 2015 Bill & Melinda Gates Foundation BMGF GLOBAL PROGRAMS
More informationPoliovirus : éradication pour les prochaines JNI?
Poliovirus : éradication pour les prochaines JNI? Bruno LINA CNR des entérovirus Laboratoire de virologie EST, GHE, HCL FRE 3011 CNRS UCBL, Lyon Polio Eradication Initiative 1 Polio Eradication Progress
More informationA vaccine s journey: the many steps to saving lives
A vaccine s journey: the many steps to saving lives GW-USAID Mini-University 7 March 2014 Endale Beyene, MA, MPH Rebecca Fields, MPH Angela Shen, ScD, MPH Outline I. What is the problem and where are we
More informationPolio Eradication and Surveillance. December
Polio Eradication and Surveillance December 2017 1 Acute Flaccid Paralysis (AFP) surveillance for polio eradication: >100,000 reported AFP per year December 2017 2 Global Laboratory Network for Polio Eradication
More informationGlobal health and vaccination: TB & beyond. Dr Mary Moran Executive Director
Global health and vaccination: TB & beyond Dr Mary Moran Executive Director mmoran@policycures.org Outline About Policy Cures 3 reasons to focus on vaccine innovation Where are we today? The pipeline Where
More informationGlobal Immunizations:
Global Immunizations: Resource Library American Academy of Pediatrics, 2014 Global distribution of deaths among children under five (2012) 6.6 million children died in 2012 More than half due to conditions
More informationGlobal Immunization Vision and Strategies (GIVS) Vaccine Tender , Pretender Meeting, Copenhagen December 2008
Global Immunization Vision and Strategies (GIVS) 2006-2015 Vaccine Tender 2010-2012, Pretender Meeting, Copenhagen 10-11 December 2008 Dr Ahmed Magan & Dr Osman David Mansoor Programme Division UNICEF
More informationTODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE
TODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE Aurélia Nguyen Tuesday 20 January 2015, Veyrier-du-Lac, France www.gavi.org AGENDA Market
More informationStrategies to Control Pneumonia and Diarrhoea: Tackling the deadliest diseases for the world s poorest children
Strategies to Control Pneumonia and Diarrhoea: Tackling the deadliest diseases for the world s poorest children Dr. Mark W. Young Senior Health Specialist UNICEF Programme Division New York September 24,
More informationTECHNICAL UPDATE: POLIO ERADICATION AND ROUTINE IMMUNIZATION STRENGTHENING. Gavi Board pre-meeting December 9, 2014, Geneva.
TECHNICAL UPDATE: POLIO ERADICATION AND ROUTINE IMMUNIZATION STRENGTHENING Gavi Board pre-meeting December 9, 2014, Geneva www.gavi.org SESSION OUTLINE Global polio eradication update Overview of Polio
More informationCountdown to 2015: tracking progress, fostering accountability
Countdown to 2015: tracking progress, fostering accountability Countdown to 2015 is a global movement to track, stimulate and support country progress towards achieving the health-related Millennium Development
More informationFunctional effective Supra-national TB Reference Laboratory Network. Dr Gavin Macgregor-Skinner Senior Laboratory Advisor (TB) USAID Washington
Functional effective Supra-national TB Reference Laboratory Network Dr Gavin Macgregor-Skinner Senior Laboratory Advisor (TB) USAID Washington USAID TB Priority Countries Category Countries Focus Countries
More informationWorld Immunization Week 2013
CAMPAIGN ESSENTIALS World Immunization Week 2013 Protect your world get vaccinated World Health Organization 2013. All rights reserved. Document number: WHO/World-Immunization-Week/2013.1 This document
More informationGlobal ProhrammeUpdate?
Global ProhrammeUpdate? Polio Partners Group Meeting, Geneva, 3 December 218 On behalf of the GPEI : Michel Zaffran, Director Polio Eradication, WHO / Chairman, GPEI Strategy Committee 1 WildPoliovirus
More informationGlobal and Regional update on Polio Eradication Activities. Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018
Global and Regional update on Polio Eradication Activities Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018 Presentation Outline 1. Background information 2. Poliovirus detection & interruption
More informationGlobal measles and polio initiative
Global measles and polio initiative Executive summary As part of its contribution to child survival programming, the International Federation s Global Measles and Polio Initiative aims to enable Red Cross
More informationPOLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12
5 August 9 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, August 4 September 9 POLIOMYELITIS ERADICATION: PROGRESS REPORT Information Document CONTENTS
More informationHow does Gavi make vaccine investment decisions?
How does Gavi make vaccine investment decisions? Judith Kallenberg Global Vaccine and Immunization Research Forum Johannesburg, South-Africa, 16 March 2016 www.gavi.org Vaccine Investment Strategy (VIS)
More informationRUSSIA Mobilizing support for the Global Fund to Fight AIDS, Tuberculosis, and Malaria
RUSSIA 3.1 HEALTH FINANCING AND STRENGTHENING HEALTH SYSTEMS 3.1.1 We will continue our efforts towards the goal of providing at least a projected US$ 60 billion to fight infectious diseases and improve
More informationBeyond effectiveness: research on vaccines seen as a continuum
Beyond effectiveness: research on vaccines seen as a continuum Alejandro Cravioto, MD, PhD Facultad de Medicina, Universidad Nacional Autónoma de México Chair, Strategic Advisory Group of Experts (SAGE)
More informationWhy does Diarrhea matter? PREVENTING MORE THAN ONE MILLION UNNECESSARY DEATHS EVERY YEAR
Why does Diarrhea matter? PREVENTING MORE THAN ONE MILLION UNNECESSARY DEATHS EVERY YEAR Presentation made at CORE GROUP on February 16, 2012 Dyness Kasungami, Child Health Team Leader, MCHIP Presentation
More informationPneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division
Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook UNICEF Supply Division Update: October 2013 0 Pneumococcal Conjugate Vaccine (PCV) Supply & Demand Outlook October 2013 Update Key updates
More informationStatus of Outbreak Vulnerable Countries
Status of Outbreak Vulnerable Countries Hamid Jafari, WHO Robert Linkins, CDC Independent Monitoring Board Meeting 7-8 May, 2013 Outline Non-Endemic Vulnerable & At-Risk Countries Recently infected countries
More informationUNICEF Programme Updates
UNICEF Programme Updates Vaccine Industry Consultation 15 16 November 2016 UNICEF/UNI199159/Panday Heather Deehan, Chief, Vaccine Centre on behalf of Robin Nandy, Principle Advisor, Immunization Outline
More informationINVESTING IN A NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA
Photo by Dominic Chavez INVESTING IN A NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA Private Sector Engagement in the Global Financing Facility in Support of Every Woman Every Child 1 www.globalfinancingfacility.org
More informationKeynote Address: The Challenge of Achieving Universal Access to Vaccines
Keynote Address: The Challenge of Achieving Universal Access to Vaccines & AMF Seth Berkley M.D, CEO www.gavi.org 1 Vaccine landscape The world before vaccines Examples of major disease outbreaks Yellow
More informationVPD in Mediterranean Basin and Black Sea: the Polio case
Screening practices for infectious diseases among newly arrived migrants and Vaccine Preventable Disease (VPD): strategies and coverage ISS 29 MAY 2015 VPD in Mediterranean Basin and Black Sea: the Polio
More informationToyako Framework for Action on Global Health - Report of the G8 Health Experts Group -
Toyako Framework for Action on Global Health - Report of the G8 Health Experts Group - 8 July 2008 This report is the recommendation from the G8 Health Experts Group to the G8 leaders. I Introduction 1.
More informationFifth report of Committee A
SIXTY-EIGHTH WORLD HEALTH ASSEMBLY (Draft) A68/73 26 May 2015 Fifth report of Committee A (Draft) Committee A held its twelfth and thirteenth meetings on 25 May 2015 under the chairmanship of Dr Eduardo
More information